These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 33124553)

  • 1. Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics.
    Harding-Esch EM; Huntington SE; Harvey MJ; Weston G; Broad CE; Adams EJ; Sadiq ST
    Euro Surveill; 2020 Oct; 25(43):. PubMed ID: 33124553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of
    Turner KM; Christensen H; Adams EJ; McAdams D; Fifer H; McDonnell A; Woodford N
    BMJ Open; 2017 Jun; 7(6):e015447. PubMed ID: 28615273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.
    Unemo M
    BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea.
    Unemo M; Golparian D; Eyre DW
    Methods Mol Biol; 2019; 1997():37-58. PubMed ID: 31119616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands.
    Xiridou M; Lugnér A; de Vries HJ; van Bergen JE; Götz HM; van Benthem BH; Wallinga J; van der Sande MA
    Sex Transm Dis; 2016 Sep; 43(9):542-8. PubMed ID: 27513379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
    Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
    APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial-resistant gonorrhoea: the national public health response, England, 2013 to 2020.
    Merrick R; Cole M; Pitt R; Enayat Q; Ivanov Z; Day M; Sun S; Sinka K; Woodford N; Mohammed H; Fifer H
    Euro Surveill; 2022 Oct; 27(40):. PubMed ID: 36205171
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019.
    Adamson PC; Van Le H; Le HHL; Le GM; Nguyen TV; Klausner JD
    BMC Infect Dis; 2020 Nov; 20(1):809. PubMed ID: 33153450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany.
    Selb R; Jansen K; Eckardt M; Tamminga T; Dudareva S; Gassowski M; Graeber I; Guhl E; Heuer D; Buder S;
    BMC Infect Dis; 2020 Jul; 20(1):514. PubMed ID: 32677988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts.
    Unemo M; Lahra MM; Cole M; Galarza P; Ndowa F; Martin I; Dillon JR; Ramon-Pardo P; Bolan G; Wi T
    Sex Health; 2019 Sep; 16(5):412-425. PubMed ID: 31437420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
    Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M
    BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
    Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
    Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.
    Ross JD; Harding J; Duley L; Montgomery AA; Hepburn T; Tan W; Brittain C; Meakin G; Sprange K; Thandi S; Jackson L; Roberts T; Wilson J; White J; Dewsnap C; Cole M; Lawrence T
    Health Technol Assess; 2019 May; 23(20):1-104. PubMed ID: 31099330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.
    Kubanova A; Kubanov A; Frigo N; Solomka V; Semina V; Vorobyev D; Khairullin R; Unemo M
    BMC Infect Dis; 2014 Jun; 14():342. PubMed ID: 24947981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
    Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
    BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is previous azithromycin treatment associated with azithromycin resistance in
    Clifton S; Town K; Furegato M; Cole M; Mohammed H; Woodhall SC; Kevin Dunbar J; Fifer H; Hughes G
    Sex Transm Infect; 2018 Sep; 94(6):421-426. PubMed ID: 29511067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility testing and molecular characterization of
    Zolfaghari P; Emamie AD; Rajabpour M; Zarei A; Whiley DM; Pourmand MR; Pourmand G
    Int J STD AIDS; 2022 Jun; 33(7):660-665. PubMed ID: 35485393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility in
    Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
    Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agent-based modelling study of antimicrobial-resistant Neisseria gonorrhoeae transmission in men who have sex with men: towards individualised diagnosis and treatment.
    Zienkiewicz AK; Verschueren van Rees N; Homer M; Ong JJ; Christensen H; Hill D; Looker KJ; Horner P; Hughes G; Turner KME
    Sex Health; 2019 Sep; 16(5):514-522. PubMed ID: 31476277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.